Clinical Trials · NCT03457012
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 462
- Start date
- Mar 2018
- Locations
- 1 site, Canada
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)